DK1842920T4 - Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein - Google Patents

Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein Download PDF

Info

Publication number
DK1842920T4
DK1842920T4 DK07109353.8T DK07109353T DK1842920T4 DK 1842920 T4 DK1842920 T4 DK 1842920T4 DK 07109353 T DK07109353 T DK 07109353T DK 1842920 T4 DK1842920 T4 DK 1842920T4
Authority
DK
Denmark
Prior art keywords
vitamin
dependent protein
reductase
productivity
cells
Prior art date
Application number
DK07109353.8T
Other languages
English (en)
Other versions
DK1842920T3 (da
Inventor
Darrel Stafford
Tao Li
Original Assignee
Univ North Carolina Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34393028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1842920(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ North Carolina Chapel Hill filed Critical Univ North Carolina Chapel Hill
Publication of DK1842920T3 publication Critical patent/DK1842920T3/da
Application granted granted Critical
Publication of DK1842920T4 publication Critical patent/DK1842920T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
DK07109353.8T 2003-09-23 2004-09-23 Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein DK1842920T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50552703P 2003-09-23 2003-09-23
EP04789039.7A EP1670947B1 (en) 2003-09-23 2004-09-23 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage

Publications (2)

Publication Number Publication Date
DK1842920T3 DK1842920T3 (da) 2010-05-03
DK1842920T4 true DK1842920T4 (da) 2017-08-21

Family

ID=34393028

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07109353.8T DK1842920T4 (da) 2003-09-23 2004-09-23 Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein
DK11156979.4T DK2380985T3 (da) 2003-09-23 2004-09-23 Celler, der udtrykker vitamin K-epoxid-reduktase, samt deres anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11156979.4T DK2380985T3 (da) 2003-09-23 2004-09-23 Celler, der udtrykker vitamin K-epoxid-reduktase, samt deres anvendelse

Country Status (13)

Country Link
US (6) US7687233B2 (da)
EP (4) EP2336360A1 (da)
JP (4) JP2007506433A (da)
AT (1) ATE455174T1 (da)
AU (2) AU2004275828B2 (da)
CA (1) CA2539434C (da)
DE (1) DE602004025157D1 (da)
DK (2) DK1842920T4 (da)
ES (2) ES2339710T5 (da)
HK (1) HK1093223A1 (da)
PL (1) PL1842920T5 (da)
PT (1) PT2380985E (da)
WO (1) WO2005030039A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2339710T5 (es) 2003-09-23 2017-10-05 University Of North Carolina At Chapel Hill Células que coexpresan vitamina K reductasa y proteína dependiente de vitamina K y uso de las mismas para mejorar la productividad de dicha proteína dependiente de vitamina K
EP1673450B1 (en) * 2003-10-14 2010-04-28 Baxter International Inc. Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
CA2575878A1 (en) * 2004-08-02 2006-02-09 Novozymes A/S Creation of diversity in polypeptides
US7445896B2 (en) 2004-10-18 2008-11-04 University Of Washington Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
EP1809767B1 (en) * 2004-10-18 2011-09-07 University of Washington Methods and compositions for predicting response to warfarin
NZ556461A (en) * 2004-12-21 2009-12-24 Academia Sinica Genetic variants of vkorc1 predicting warfarin sensitivity
WO2006089613A1 (en) 2005-02-28 2006-08-31 Baxter International Inc. Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
US20090325226A1 (en) 2005-03-15 2009-12-31 Stafford Darrel W Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
EP1874928A1 (en) * 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US8500720B2 (en) * 2005-05-09 2013-08-06 Medtronic, Inc Method and apparatus for treatment of cardiac disorders
US20080045453A1 (en) * 2005-12-21 2008-02-21 Drohan William N Method of producing biologically active vitamin K dependent proteins by recombinant methods
TW200808976A (en) * 2006-06-02 2008-02-16 Pharmigene Inc Warfarin dosage prediction
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
MX2010011672A (es) 2008-04-24 2011-03-02 Celtic Pharma Peg Ltd Conjugados del factor ix con vidas medias extendidas.
WO2010045381A2 (en) * 2008-10-15 2010-04-22 President And Fellows Of Harvard College Antimicrobial agents that target bacterial vkor
CN102471794B (zh) 2009-07-10 2014-10-29 Csl有限公司 提高维生素k依赖性蛋白质的表达产量的方法
US9631002B2 (en) 2010-12-21 2017-04-25 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin K-dependent proteins
JP2012139232A (ja) * 2012-03-15 2012-07-26 Univ Of North Carolina At Chapel Hill 活性ビタミンｋ依存性タンパク質を生産するための方法及び組成物
JP2014221048A (ja) * 2014-06-16 2014-11-27 ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 活性ビタミンｋ依存性タンパク質を生産するための方法及び組成物
BR102015012334A2 (pt) * 2015-05-27 2016-11-29 Fundação Hemoct De Ribeirão Preto Fundherp processo de produção do fator vii de coagulação sanguínea e fator vii de coagulação sanguínea
WO2018106959A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018112264A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
WO2020106757A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US11707610B2 (en) 2019-12-13 2023-07-25 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4736866A (en) * 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
US4770999A (en) 1985-04-22 1988-09-13 Genetics Institute, Inc. High yield production of active Factor IX
ATE87659T1 (de) 1986-09-02 1993-04-15 Enzon Lab Inc Bindungsmolekuele mit einzelpolypeptidkette.
EP0289586A4 (en) 1986-11-17 1990-04-10 New England Medical Ct INCREASING GAMMA CARBOXYLATION OF RECOMBINANT, VITAMIN K-DEPENDENT PROTEINS.
EP0380508A4 (en) 1987-05-18 1991-04-03 Integrated Genetics, Inc. Improved protein c molecules and method for making and activating same
AU634186B2 (en) 1988-11-11 1993-02-18 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
WO1991001372A1 (en) 1989-07-17 1991-02-07 New England Medical Center Hospitals, Inc. VITAMIN K-DEPENDENT η-CARBOXYLASE
CA2087970A1 (en) * 1990-07-23 1992-01-24 Kathleen L. Berkner Gamma-carboxylase and methods of use
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5169784A (en) 1990-09-17 1992-12-08 The Texas A & M University System Baculovirus dual promoter expression vector
IE914102A1 (en) 1990-11-26 1992-06-03 Genetics Inst Expression of pace in host cells and methods of use thereof
US5965789A (en) 1991-01-11 1999-10-12 American Red Cross Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
US5268275A (en) 1991-05-08 1993-12-07 The University Of North Carolina At Chapel Hill Vitamin K-dependent carboxylase
DK0605522T3 (da) 1991-09-23 2000-01-17 Medical Res Council Fremgangsmåde til fremstilling af humaniserede antistoffer
US5698765A (en) * 1991-12-02 1997-12-16 The Ontario Cancer Institute Mouse having a disrupted CD4 gene
WO1993018144A1 (en) * 1992-03-05 1993-09-16 The Trustees Of Columbia University Of The City Of New York Recombination activating gene deficient animal
US5625122A (en) * 1992-04-24 1997-04-29 The Ontario Cancer Institute Mouse having a disrupted lck gene
JP3741447B2 (ja) * 1992-10-23 2006-02-01 中外製薬株式会社 エンドセリン−１遺伝子の機能が欠損したマウス
DE69433811T2 (de) * 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
AU2860295A (en) 1994-06-16 1996-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Defects in drug metabolism
ZA965853B (en) * 1995-07-13 1998-01-12 Du Pont Merck Pharma Asymmetric synthesis of r and s warfarin and its analogs.
DE19625049A1 (de) 1996-06-22 1998-01-02 Inst Pflanzengenetik & Kultur Transgenes, nicht-menschliches Säugetier, das ein zusätzliches DNA-Reparaturgen enthält
WO2003004622A2 (en) * 2001-03-21 2003-01-16 Human Genome Sciences, Inc. Human secreted proteins
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
US6531298B2 (en) 1997-07-21 2003-03-11 The University Of North Carolina At Chapel Hill Factor IX antihemophilic factor with increased clotting activity
EP1042473A1 (en) 1997-12-24 2000-10-11 Immunex Corporation V201 dna and polypeptides
US5896337A (en) 1998-02-23 1999-04-20 Micron Technology, Inc. Circuits and methods for multi-level data through a single input/ouput pin
CA2332307A1 (en) * 1998-07-10 2000-01-20 Incyte Pharmaceuticals, Inc. Human transport protein homologs
EP1048054B1 (en) * 1998-11-18 2003-09-24 Koninklijke Philips Electronics N.V. Luminescent material
WO2000054787A1 (en) 1999-03-16 2000-09-21 The Children's Hospital Of Philadelphia Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors
US6453244B1 (en) * 2000-02-10 2002-09-17 Stanford University Detection of polymorphisms by denaturing high-performance liquid chromatography
US6492115B1 (en) * 2000-06-02 2002-12-10 Dna Sciences Laboratories, Inc. Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods
US6903069B2 (en) 2000-10-02 2005-06-07 Novo Nordisk Health Care A/S Factor VII glycoforms
AU2002226028A1 (en) 2000-11-14 2002-05-27 Board Of Regents, Unversity Of Texas Systems Mutant human factor ix with an increased resistance to inhibition by heparin
ES2339710T5 (es) * 2003-09-23 2017-10-05 University Of North Carolina At Chapel Hill Células que coexpresan vitamina K reductasa y proteína dependiente de vitamina K y uso de las mismas para mejorar la productividad de dicha proteína dependiente de vitamina K
EP1673450B1 (en) 2003-10-14 2010-04-28 Baxter International Inc. Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
GB0324044D0 (en) * 2003-10-14 2003-11-19 Astrazeneca Ab Protein
US7445896B2 (en) * 2004-10-18 2008-11-04 University Of Washington Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
EP1809767B1 (en) 2004-10-18 2011-09-07 University of Washington Methods and compositions for predicting response to warfarin
WO2006067116A1 (en) 2004-12-21 2006-06-29 Novo Nordisk Health Care Ag Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems
NZ556461A (en) * 2004-12-21 2009-12-24 Academia Sinica Genetic variants of vkorc1 predicting warfarin sensitivity
WO2006089613A1 (en) * 2005-02-28 2006-08-31 Baxter International Inc. Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
US20090325226A1 (en) * 2005-03-15 2009-12-31 Stafford Darrel W Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
EP1874928A1 (en) 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US8647868B2 (en) 2005-12-02 2014-02-11 Wake Forest University Health Sciences Compositions and methods for increasing production of recombinant gamma-carboxylated proteins
US20080045453A1 (en) 2005-12-21 2008-02-21 Drohan William N Method of producing biologically active vitamin K dependent proteins by recombinant methods
TW200808976A (en) * 2006-06-02 2008-02-16 Pharmigene Inc Warfarin dosage prediction
JP2009005240A (ja) * 2007-06-25 2009-01-08 Nec Tokin Corp 無線ネットワークシステムおよび無線ネットワーク通信方法

Also Published As

Publication number Publication date
JP5840539B2 (ja) 2016-01-06
EP1670947A4 (en) 2008-11-05
ES2339710T3 (es) 2010-05-24
US8097410B2 (en) 2012-01-17
PT2380985E (pt) 2014-03-26
WO2005030039A3 (en) 2005-07-21
DK1842920T3 (da) 2010-05-03
PL1842920T3 (pl) 2010-06-30
DK2380985T3 (da) 2014-03-17
US7482141B2 (en) 2009-01-27
HK1093223A1 (en) 2007-02-23
US20070190614A1 (en) 2007-08-16
US7524665B2 (en) 2009-04-28
US8426128B2 (en) 2013-04-23
CA2539434A1 (en) 2005-04-07
JP2012161315A (ja) 2012-08-30
US20070009950A1 (en) 2007-01-11
ES2453895T3 (es) 2014-04-08
DE602004025157D1 (de) 2010-03-04
EP1842920B1 (en) 2010-01-13
AU2004275828A1 (en) 2005-04-07
US20110124000A1 (en) 2011-05-26
CA2539434C (en) 2014-03-18
EP1842920A1 (en) 2007-10-10
JP5094920B2 (ja) 2012-12-12
EP1670947A2 (en) 2006-06-21
US20090215061A1 (en) 2009-08-27
US7858318B2 (en) 2010-12-28
EP2380985A1 (en) 2011-10-26
EP2380985B1 (en) 2014-01-01
EP1670947B1 (en) 2015-04-01
JP2015180205A (ja) 2015-10-15
ATE455174T1 (de) 2010-01-15
ES2339710T5 (es) 2017-10-05
JP2010268803A (ja) 2010-12-02
AU2010203318B2 (en) 2012-07-12
JP2007506433A (ja) 2007-03-22
US20090215045A1 (en) 2009-08-27
US20060240440A1 (en) 2006-10-26
WO2005030039A2 (en) 2005-04-07
AU2004275828B2 (en) 2010-04-29
AU2010203318A1 (en) 2010-08-12
EP2336360A1 (en) 2011-06-22
EP1842920B2 (en) 2017-06-21
US7687233B2 (en) 2010-03-30
PL1842920T5 (pl) 2018-04-30

Similar Documents

Publication Publication Date Title
DK1842920T3 (da) Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein
ATE330038T1 (de) Nukleinsäure-biosensor
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
AU2003241311A8 (en) Simple catalytic dna biosensors for ions based on color changes
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
DK1680516T3 (da) Ruminddelt autonom mærkning
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
WO2006069339A3 (en) Genetic variants of vkorci predicting warfarin sensitivity
ATE444377T1 (de) Nukleinsäurecharakterisierung
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
IL172910A0 (en) Method for detection of alkylated cytosine in dna
DE60330399D1 (de) Trichmikroskopie, kultur und polymerasekettenreaktion unter verwendung prozessierter klinischer proben und kit davon
EA200701742A1 (ru) Способы получения сиропа
ATE445158T1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
DE502005008373D1 (de) Polymorphismen im nod2/card15 gen
DE60228089D1 (de) Nukleinsäureamplifikation mit duplexzwischenprodukten
WO2007067557A3 (en) Methods for cyclic nucleotide determination
ATE443261T1 (de) Scintillation proximity assay
EP1829979A4 (en) GENE IDENTIFICATION METHOD WITH VARIABLE EXPRESSION
BRPI0515397B8 (pt) métodos para detecção e identificação específicas de streptococcus agalactiae usando atividade de esterase, e meio de reação
ATE489483T1 (de) Assoziation von pde4d-allelvarianten mit schlaganfall
WO2005003388A3 (en) Fluorescence assays for nucleic acid polymerase activity
SE0402128D0 (sv) New product
ATE465248T1 (de) Humane cyclooxygenase-3 und ihre verwendung
WO2004035824A3 (en) Method of detecting polymorphisms affecting transcriptional activity